XML 41 R4.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]        
Total gross sales $ 9,703,800 $ 7,752,478 $ 20,116,291 $ 8,436,207
Allowances (304,764) (2,115,900) (569,019) (2,333,942)
Total net sales 9,399,036 5,636,578 19,547,272 6,102,265
Costs of sales 2,732,076 1,914,716 6,432,613 2,080,027
Gross profit 6,666,960 3,721,862 13,114,659 4,022,238
Operating expenses 12,267,637 5,749,463 24,827,934 7,141,274
Income (loss) from operations (5,600,677) (2,027,601) (11,713,275) (3,119,036)
Realized and unrealized gain (loss) on marketable securities (53,152) 9,524 (115,162) (64,640)
Impairment on investment other securities (600,000) 0 (600,000) 0
Impairment accounts receivable other (160,000) 0 (160,000) 0
(Increase) decrease on contingent liability 21,261,994 (30,914,074) 38,160,000 (30,914,074)
Interest income 35,607 6,274 42,875 43,959
Income (loss) before provision for income taxes 14,883,772 (32,925,877) 25,614,438 (34,053,791)
Benefit for income taxes 0 1,075,000 2,240,300 1,208,000
Net income (loss) from continuing operations 14,883,772 (31,850,877) 27,854,738 (32,845,791)
Net loss from discontinued operations, net of tax (Note 15) 0 603 (41,202) (1,193,345)
Net income (loss) 14,883,772 (31,850,274) 27,813,536 (34,039,136)
Net loss attributable to non-controlling interest 0 (58,536) 0 (137,685)
Preferred dividends 100,016 0 166,750 0
Net income (loss) attributable to cbdMD, Inc. common shareholders $ 14,783,756 $ (31,791,738) $ 27,646,786 $ (33,901,451)
Net income (loss) per share:        
Basic earnings per share $ 0.41 $ (3.13) $ 0.76 $ (3.35)
Diluted earnings per share $ .40 $ .00 $ 0.74 $ .00
Weighted average number of shares - basic 36,503,005 10,160,947 36,503,005 10,107,144
Weighted average number of shares - diluted 37,336,505 10,160,947 37,336,505 10,107,144